$NBIO - "This notice of allowance provides further
Post# of 104396
(Total Views: 162)
Posted On: 07/19/2022 1:27:48 PM
$NBIO - "This notice of allowance provides further validation of our novel approach to treat brain cancers with Pritumumab, a unique natural antibody capable of crossing the blood brain barrier," said Sean Carrick, CEO of Nascent. "This patent represents a critical step in protecting our technology and establishing Nascent as the leader in treating vimentin-expressing tumors."
https://finance.yahoo.com/news/nascent-biotec...00617.html
https://finance.yahoo.com/news/nascent-biotec...00617.html
(0)
(0)Scroll down for more posts ▼